Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Envista HoldingsSTU:0HV -1.67%78 Beneish M-Score is -2.53 as of Aug. 03, 2026. GuruFocus rates STU:0HV with a GF Score™ of 78/100 and a GF Value™ of €20.85 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 762 Medical Devices & Instruments companies, Envista Holdings ranks worse than 54.99% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Good Sign:
Beneish M-Score -2.53 no higher than -1.78, which implies that the company is unlikely to be a manipulator.
The historical rank and industry rank for Envista Holdings's Beneish M-Score or its related term are showing as below:
STU:0HV'
s Beneish M-Score Range Over the Past 10 Years
Min: -3.98 Med: -2.56 Max: -2.17
Current: -2.53
During the past 10 years, the highest Beneish M-Score of Envista Holdings was -2.17. The lowest was -3.98. And the median was -2.56.
The historical data trend for Envista Holdings's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:0HV vs MMSI, ICUI, MMED: Beneish M-Score Comparison
For the Medical Instruments & Supplies subindustry, Envista Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envista Holdings Beneish M-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Envista Holdings's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Envista Holdings for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 1.0001
+
0.528 * 0.9849
+
0.404 * 0.9856
+
0.892 * 1.0386
+
0.115 * 1.0421
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 0.9276
+
4.679 * -0.031258
-
0.327 * 1.0033
=
-2.59
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(140.399 / (140.399 + 387.02))
/
(131.253 / (131.253 + 382.589))
=
0.2662
/
0.255435
=
1.0421
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(58.645 - -23.87
-
233.333)
/
4824.97
=
-0.031258
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Envista Holdings has a M-score of -2.59 suggests that the company is unlikely to be a manipulator.
Envista Holdings (STU:0HV) has a Beneish M-Score of -2.53 as of Aug. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Envista Holdings and its competitors. According to the industry distribution chart, Envista Holdings ranks #419 out of 762 companies in the Medical Devices & Instruments industry, placing it in the top 55%.
Is Envista Holdings' Beneish M-Score too high?
Envista Holdings' current Beneish M-Score is -2.53. Based on the distribution chart, Envista Holdings ranks #419 out of 762 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Envista Holdings has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Envista Holdings' Beneish M-Score compare to MMSI and ICUI?
According to the Medical Devices & Instruments industry distribution chart, Envista Holdings ranks #419 out of 762 companies for Beneish M-Score. This places Envista Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Envista Holdings and its competitors. Envista Holdings's current Beneish M-Score is -2.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envista Holdings stock overvalued right now?
Based on GuruFocus' analysis, Envista Holdings (STU:0HV) is currently considered Modestly Overvalued. The stock's GF Value™ is €20.85, compared to a current price of €23.60 — trading 13.2% above its estimated fair value. The current Beneish M-Score is -2.53. Envista Holdings' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Envista Holdings (STU:0HV), the current Beneish M-Score is -2.53 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Envista Holdings (STU:0HV) Overvalued in 2026?
Based on GuruFocus' analysis, Envista Holdings stock appears to be overvalued.
The current stock price of €23.60 is trading 13.2% above its estimated GF Value™ of €20.85.
GuruFocus considers Envista Holdings to be Modestly Overvalued.
Key valuation signals for STU:0HV:
Beneish M-Score: -2.53
GF Value™: €20.85 vs. price of €23.60 (13.2% above fair value)
No single metric tells the full story. See the STU:0HV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
78GF Score
Get the complete analysis for STU:0HV
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:0HV has been successfully added to your 
